Evaluation of Retinal Changes in Progressive Supranuclear Palsy and Parkinson Disease

被引:17
|
作者
Sevim, Duygu Gulmez [1 ]
Unlu, Metin [1 ]
Gultekin, Murat [2 ]
Karaca, Cagatay [1 ]
Mirza, Meral [2 ]
Mirza, Galip Ertugrul [1 ]
机构
[1] Erciyes Univ, Fac Med, Dept Ophthalmol, TR-38039 Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Neurol, Kayseri, Turkey
关键词
SEVERITY; ASSOCIATION; LEVODOPA;
D O I
10.1097/WNO.0000000000000591
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Differentiating Parkinson disease (PD) from progressive supranuclear palsy (PSP) can be challenging early in the clinical course. The aim of our study was to see if specific retinal changes could serve as a distinguishing feature. Methods: We used spectral domain optical coherence tomography (SD-OCT) with automatic segmentation to measure peripapillary nerve fiber layer thickness and the thickness and volume of retinal layers at the macula. Results: Thicknesses of superior peripapillary retinal nerve fiber layer (pRNFL), macular ganglion cell layer, inner plexiform layer, inner nuclear layer, and macular volume were more affected in PSP compared with PD (P < 0.05). Thicker inferotemporal pRNFL and lower macular volume were detected in levodopa users compared with nonusers in patients with PD. Conclusions: PD and PSP are associated with distinct changes in retinal morphology, which can be assessed with SD-OCT. (C) 2017 by North American Neuro-Ophthalmology Society
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [1] Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
    Talai, Aron S.
    Sedlacik, Jan
    Boelmans, Kai
    Forkert, Nils D.
    NEUROIMAGE-CLINICAL, 2018, 20 : 1037 - 1043
  • [2] STRIATAL PHOSPHOPROTEINS IN PARKINSON DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY
    GIRAULT, JA
    RAISMANVOZARI, R
    AGID, Y
    GREENGARD, P
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (07) : 2493 - 2497
  • [3] Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy
    Chen, Yueting
    Wang, Haotian
    Wang, Bo
    Li, Wenbo
    Ye, Panpan
    Xu, Wen
    Liu, Peng
    Chen, Xinhui
    Cen, Zhidong
    Ouyang, Zhiyuan
    Wu, Sheng
    Dou, Xiaofeng
    Liao, Yi
    Zhang, Hong
    Tian, Mei
    Luo, Wei
    JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (01) : 55 - 63
  • [4] The subthalamic nucleus in Parkinson's disease and progressive supranuclear palsy
    Hardman, CD
    Halliday, GM
    McRitchie, DA
    Morris, JGL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1997, 56 (02): : 132 - 142
  • [7] Parkinson disease and progressive supranuclear palsy: protein expression in skin
    Rodriguez-Leyva, Ildefonso
    Chi-Ahumada, Erika G.
    Carrizales, Juan
    Rodriguez-Violante, Mayela
    Velazquez-Osuna, Salvador
    Medina-Mier, Veronica
    Martel-Gallegos, Maria G.
    Zarazua, Sergio
    Enriquez-Macias, Lourdes
    Castro, Adriana
    Laura Calderon-Garciduenas, Ana
    Jimenez-Capdeville, Maria E.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (03): : 191 - 199
  • [8] Retinal thickness as a marker of disease progression in progressive supranuclear palsy
    Chen, Y.
    Wang, H.
    Wang, B.
    Li, B.
    Ye, P.
    Xu, W.
    Liu, P.
    Chen, X.
    Cen, Z.
    Ouyang, Z.
    Wu, S.
    Dou, X.
    Liao, Y.
    Luo, W.
    MOVEMENT DISORDERS, 2022, 37 : S488 - S488
  • [9] Complement system changes in blood in Parkinson's disease and progressive Supranuclear Palsy/Corticobasal Syndrome
    Khosousi, Shervin
    Hye, Abdul
    Velayudhan, Latha
    Bloth, Bjorn
    Tsitsi, Panagiota
    Markaki, Ioanna
    Svenningsson, Per
    PARKINSONISM & RELATED DISORDERS, 2023, 108
  • [10] The comparison of urinary dysfunction in Parkinson's disease and progressive supranuclear palsy
    Zalyalova, Z.
    Bogdanov, E.
    Kalashnikova, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 561 - 561